期刊文献+

T1和T2期结直肠癌淋巴结转移与相关分子标记物表达的关系 被引量:9

Expression of molecular markers detected by immunohistochemistry and risk of lymph nodemetastasis in stage T1 and T2 colorecrectal cancers
原文传递
导出
摘要 目的探讨影响T1~1、2期结直肠癌淋巴结转移与相关分子标记物表达的关系。方法采用组织芯片和免疫组化技术检测行根治性切除的T1~T2期结直肠癌组织的血管内皮生长因子受体3(VEGFR-3)、表皮生长因子受体(EGFR)、人类表皮生长因子2(HER-2)、胰岛素样生长因子受体1(IGF-1R)、胰岛素样生长因子2(IGF-2)、胰岛素样生长因子结合蛋白1(IGFBP-1)、E-钙黏蛋白(ECAD)、基质金属蛋白酶9(MMP-9)、金属蛋白酶组织抑制剂1(TIMP-1)、Raf激酶抑制蛋白(RKIP)、趋化因子受体4(CXCR4)、微卫星不稳定(MSI)、CD44v6和CDl33的表达情况,采用Logistic回归分析相关分子标记物与淋巴结转移的关系。结果结直肠癌组织中VEGFR-3、EGFR、HER-2、IGF-1R、IGF-2、IGFBP-1、ECAD、CD44v6、MMP-9、TIMP-1、RKIP、CXCR4和CDl33蛋白的表达率分别为44.3%、30.5%、28.1%、63.5%、44.8%、70.9%、45.8%、51.2%、44.3%、41.4%、45.3%、40.9%和49.8%,MSI阳性率为22.2%。Logistic回归分析结果显示,VEGFR-3、HER-2和TIMP-1的表达与淋巴结转移有关。结论VEGFR-3、HER-2和TIMP-1是影响¨~T2期结直肠癌淋巴结转移的独立因素。 Objective To study the molecular risk factors of lymph node metastasis in stage T1 and T2 colorectal cancers by tissue microarray and immunohistochemistry techniques. Methods Two hundred and three patients with stage T1 and T2 colorectal carcinoma who underwent radical surgery from 1999 to 2010 in our department were included in this study. Their clinicopathological data were retrospectively analyzed. Expression of the following 14 molecular markers were selected and assayed by tissue microarray and immunohistochemistry: VEGFR-3, HER2, CD44v6, CXCR4, TIMP-1, EGFR, IGF-1R, IGF-2, IGFBP-1, ECAD, MMP-9, RKIP, CD133, MSI. Chi-squared test and logistic regression were used to evaluate the variables as potential risk factors for lymph node metastasis. Results The positive expression rates of biomarkers were as following: VEGFR-3 (44.3%) ,EGFR (30.5%), HER-2 (28.1%), IGF-1R (63.5%), IGF-2 (44. 8%), IGFBP-1 (70.9%), ECAD (45. 8%), CIM4v6 (51. 2%), MMP-9 (44.3%), TIMP-1 (41.4%), RKIP (45.3%), CXCR4 (40.9%), and CD133 (49.8%). The positive rate of MSI expression was 22.2%. Both univariate and multivariate analyses showed that VEGFR-3, HER-2, and TIMP-1 were significant predictors of lymph node metastasis. Univariate analysis showed that CD44v6 and CXCR4 were significant significant predictors of lymph node metastasis. Conclusions VEGFR-3, HER2 and TIMP-1 are independent factors for lymph node metastasis in stage T1 and T2 colorectal cancers.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2013年第4期277-281,共5页 Chinese Journal of Oncology
关键词 结直肠肿瘤 肿瘤转移 免疫组织化学 寡核苷酸序列分析 生物学标记 Colorectal neoplasms Neoplasm metastasis Immunohistochemistry Oligonueleotide array sequence analysis Biological markers
  • 相关文献

参考文献28

  • 1万德森.我国结直肠癌的流行趋势及对策[J].中华肿瘤杂志,2011,33(7):481-483. 被引量:125
  • 2Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet, 2010, 375:1030-1047. 被引量:1
  • 3van der Pas MH, Meijer S, Hoekstra OS, et al. Sentinel-lymph- node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol, 2011, 12:540-550. 被引量:1
  • 4AI-Mulla F, Hagan S, Behbehani AI, et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol, 2006, 24:5672-5679. 被引量:1
  • 5Su JL, Yen CJ, Chen PS, et al. The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer, 2007, 96:541-545. 被引量:1
  • 6Theodoropoulos GE, Karafoka E, Papailiou JG, et al. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up. Anticancer Res, 2009, 29: 785-791. 被引量:1
  • 7Kavanagh DO, Chambers G, O'Grady L, et al. ls overexpression of HER-2 a predictor of prognosis in colorectal cancer.'?. BMC Cancer, 2009, 9 : 1. 被引量:1
  • 8耿一婷,仇金荣,王蓉,苏云涛,束永前,殷咏梅.胃癌组织中人表皮生长因子受体2和瘦素的表达及意义[J].中华肿瘤杂志,2011,33(10):764-769. 被引量:14
  • 9Zhang C, Hao L, Wang L, et al. Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer. BMC Cancer, 2010, 10:184. 被引量:1
  • 10Wolpin BM, Meyerhardt JA, Chan AT, et al. Insulin, the insulin- like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol, 2009, 27:176-185. 被引量:1

二级参考文献20

共引文献137

同被引文献73

  • 1蔡宏,莫善兢,王亚农,朱蕙燕,师英强,董锐增,施达仁,陆红芬.早期结直肠癌淋巴结转移的基础和临床研究[J].中国实用外科杂志,2005,25(5):273-277. 被引量:19
  • 2朱晓莉,林勇,唐剑英,张祖贻.C-erb B-2基因在肺癌中表达意义的临床研究[J].东南大学学报(医学版),2006,25(1):41-43. 被引量:6
  • 3屠世良,叶再元,邓高里,赵仲生,董全进,郑伯安,丁丽萍,曹鸿峰.结直肠癌淋巴结转移的规律及其影响因素[J].中华胃肠外科杂志,2007,10(3):257-260. 被引量:30
  • 4Wiese D, Sirop S, Yestrepsky B, et al. Ultrastaging of sentinel lymph nodes(SLNs) vs non-SLNs in colorectal cancer-do we need both [J~. Am J Surg,2010,199(3) :354-358. 被引量:1
  • 5Sommariva A, Donisi PM, Gnocato B, et al. Factors affecting false- negative rates on ex vivo sentinel node mapping in colorectal cancer [J]. Eur J Surg Oncol, 2010, 36(2) : 130-134. 被引量:1
  • 6Vermeeren L, van der Ploeg IM, Olmos RA, et ",d. SPECT/CT for Pre- operative sentinel node localization[ J]. Surg Oncol,2010,101 (2) : 184-190. 被引量:1
  • 7Sommariva A, Donisi PM, Gnocato B, et al. Factors 'affecting false - negative rates on ex vivo sentinel node mapping in coloreetal cancer [J]. Eur J Surg Oneol,2010,36(2) :130-134. 被引量:1
  • 8Al-Snkhnl E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis[J]. Annals of Surgical Oncology, 2012, 19(7): 2212-2223. 被引量:1
  • 9Chang HC, Huang SC, Chert JS, et al. Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review[J]. Annals of Surgical Oncology, 2012, 19(8): 2477-2484. 被引量:1
  • 10Huh JW, Kim HC, Kim SH, et al. Mismatch repair system and p53 expression in patients with TI and T2 colorectal cancer: Predictive role of lymph node metastasis and survival[J]. Journal of Surgical Oncology, 2014, 109(8): 848-852. 被引量:1

引证文献9

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部